Methods used by the body to selectively suppress the immune response may help make organ transplants safer and more effective, according to scientists. "If you like, what we are trying to do is make every tissue transplant much more like a fetus," said Dr. Andrew L.
Ambrilia Biopharma Inc. announced today that it has entered into an exclusive license option agreement with ZBx Corporation granting ZBx the worldwide rights to develop, manufacture and commercialize Ambrilia's PSP94 technology in ZBx's Zap(TM) Rapid Test Systems and Assays.
Roche Diagnostics and Australian Biotech company SMD, Southern Medical Diagnostics, today announced the signing of license agreements which provide Roche Diagnostics with semi-exclusive world-wide rights for diagnostic applications of Surfactant Protein-B in lung disorders and SMD with world-wide rig
